Table 1: Demographic and clinical characteristicsaccording to treatment modalities (n =124).

Covariates

ACT (n = 93)

NACT (n = 31)

p-value

Age

< 50 years

≥ 50 years

 

31 (33.3%)

62 (66.7%)

 

14 (45.2%)

17 (54.8%)

0.236

Ethnic

Malay

Non-Malay

54 (58.1%)

39 (41.9%)

 

24 (77.4%)

7 (22.6%)

 

0.053

Stage

Early stage

Advanced Stage

 

39 (41.9%)

54 (58.1%)

 

5 (16.1%)

26 (83.9%)

0.009

Molecular subtypes

Luminal A

TNBC

Other

 

36 (38.7%)

13 (14.0%)

44 (47.3%)

 

6 (19.4%)

5 (16.1%)

20 (64.5%)

0.137

Chemotherapy

Anthracycline based

Taxane based

Antharacycline + taxane

 

57 (61.3%)

3 (3.2%)

33 (35.5%)

 

23 (74.2%)

3 (9.7%)

5 (16.1%)

0.066

Schedule modification

No Modification

With Modification

 

41 (44.1%)

52 (55.9%)

 

13 (41.9%)

18 (58.1%)

0.834

Status

Alive

Death

 

78 (83.9%)

15 (16.1%)

 

15 (48.4%)

16 (51.6%)

< 0.001